Clinical Trial Update: Efficacy and Safety of the Fixed-dose Combination Atorvastatin/Fenofibrate vs Atorvastatin in Patients With T2D and DLP. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of a fixed-dose combination of atorvastatin and fenofibrate versus atorvastatin alone in patients with dyslipid…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Type 2 Diabetes Mellitus

Drugs mentioned

• atorvastatin (atorvastatin)
• atorvastatin/fenofibrate fixed-dose combination

Snippet

Sponsor: Laboratorios Silanes S.A. de C.V. | Conditions: Dyslipidemia Associated With Type II Diabetes Mellitus | Phase 3 | Status: UNKNOWN